Compare Bitdeer Technologies Group (BTDR) vs McKesson Corporation (MCK) Price & Performance

Bitdeer Technologies GroupTrade

McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Bitdeer Technologies Group vs McKesson Corporation — how do they compare? Bitdeer Technologies Group trades at $8.86 (market cap $2.36B), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 44.6× Bitdeer Technologies Group's market cap, and McKesson Corporation pays a 0.42% dividend while Bitdeer Technologies Group pays none. Which is the better fit depends on your goals.

	BTDR	MCK
Market Cap	$2.36B	$105.14B
Sector	Technology	Health
52-Week High	$25.90	$995.69
52-Week Low	$7.28	$659.01
Enterprise Value	$3.85B	$111.67B
Dividend Yield	—	0.42%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BTDR

Bitdeer Technologies faces uncertainty despite strong revenue growth due to Bitcoin and AI market risks.Seeking Alpha · 23 hours agoNeutral Stocks of INNOVATE Corp. and Bitdeer Technologies plunge over 20% despite positive earnings reports.Danny Green · 1 day agoBearish Bitdeer expands into AI infrastructure with a 16-year renewable energy data center lease in Norway.Tony Dante · 1 day agoNeutral View details →

MCK

View details →

About Bitdeer Technologies Group

Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.